After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels.

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Men who experience acute adverse effects after radiation therapy for prostate cancer may be at higher risk for more serious ...

Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels.

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...

Metastatic prostate cancer patients in the Capital Region now have a new treatment option at Ochsner MD Anderson Cancer ...

SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Arjun Pon Avudaiappan discussing survival ...

Results from the company’s Phase I/II trial showed the injectable therapy to have an effective half-life of 91.4 hours.

Your skilled and highly experienced team includes an endocrine surgeon, endocrinologist, pathologist, medical oncologist and radiation oncologist and dedicated nurses. These UW Medicine specialists ...

All types of radiation become less intense as they travel further away from the radioactive material. This is because the particles or rays become more spread out. The thicker the substance ...

The gene expression signature PORTOS can determine which patients with localized prostate cancer will benefit ... PORTOS could be used to help guide radiation dose-escalation and de-escalation ...